Click Therapeutics secures $50M in Series D funding led by Boehringer Ingelheim to advance its digital therapeutics for patients with schizophrenia.
Amount Raised
$50 Million
Round Type
Series D
New YorkHealthcareHealth CareInvestors
Description
Click Therapeutics, based in NYC, has closed a $50M Series D funding round from Boehringer Ingelheim. This financing will support the commercialization of CT-155, a digital therapeutic aimed at treating negative symptoms of schizophrenia. The agreement grants Boehringer full product responsibility, enhancing Click's strategic position. The investment follows FDA authorizations for its other digital therapeutics, enriching their product portfolio.
Quick answer
Click Therapeutics raised $50 Million in a Series D round, dated April 9, 2026. Investors: Boehringer Ingelheim. Click Therapeutics is based in New York, New York, United States.
- How much did Click Therapeutics raise?
- Click Therapeutics raised $50 Million in a Series D round on April 9, 2026.
- Who invested in Click Therapeutics?
- Boehringer Ingelheim is named as investors in this round.
- What does Click Therapeutics do?
- Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for patients with unmet medical needs.
- Where is Click Therapeutics based and how big is it?
- Click Therapeutics is based in New York, New York, United States. Fundz records about 171 employees.
- Who are the decision-makers at Click Therapeutics?
- Fundz holds 1 contact at Click Therapeutics, including the Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Health Care around the same time
Companies in the same sectors as Click Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Spine BioPharma raised $385K (Series B) on May 22, 2026.
- AIM ImmunoTech raised $2.4M (Post-IPO Equity) on May 20, 2026.
- IRulya Therapeutics Inc. raised $115M on May 18, 2026.
- Cagent Vascular raised $41M (Series D) on May 18, 2026.
- EnsoData raised an undisclosed amount (Debt Financing) on May 13, 2026.
- iSpecimen raised $5M (Post-IPO Equity) on May 11, 2026.
Who to call at Click Therapeutics, and when
A new round usually means Click Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Click Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Click Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Click Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Click Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Click Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.